AU1118099A - Methods of screening potential atypical antipsychotic drugs - Google Patents

Methods of screening potential atypical antipsychotic drugs

Info

Publication number
AU1118099A
AU1118099A AU11180/99A AU1118099A AU1118099A AU 1118099 A AU1118099 A AU 1118099A AU 11180/99 A AU11180/99 A AU 11180/99A AU 1118099 A AU1118099 A AU 1118099A AU 1118099 A AU1118099 A AU 1118099A
Authority
AU
Australia
Prior art keywords
methods
antipsychotic drugs
atypical antipsychotic
screening potential
potential atypical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11180/99A
Inventor
Xiaofu Liang
Rex Y. Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Publication of AU1118099A publication Critical patent/AU1118099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
AU11180/99A 1997-10-23 1998-10-23 Methods of screening potential atypical antipsychotic drugs Abandoned AU1118099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6275097P 1997-10-23 1997-10-23
US60062750 1997-10-23
PCT/US1998/022492 WO1999020315A1 (en) 1997-10-23 1998-10-23 Methods of screening potential atypical antipsychotic drugs

Publications (1)

Publication Number Publication Date
AU1118099A true AU1118099A (en) 1999-05-10

Family

ID=22044551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11180/99A Abandoned AU1118099A (en) 1997-10-23 1998-10-23 Methods of screening potential atypical antipsychotic drugs

Country Status (2)

Country Link
AU (1) AU1118099A (en)
WO (1) WO1999020315A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000079273A2 (en) * 1999-06-21 2000-12-28 Matsushita Electric Industrial Co., Ltd. Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample
US20020099076A1 (en) * 2000-05-25 2002-07-25 Richard Scheyer D. Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis
EP1462117A1 (en) * 2003-03-28 2004-09-29 Institut National de la Santé et de la Recherche Médicale (INSERM) Method for in vivo detection of antipsychotic properties of dopamine D3 receptor ligands
EP3702448A1 (en) 2019-03-01 2020-09-02 Neuroproof GmbH Neuronal network and method for monitoring excitatory and inhibitory balance

Also Published As

Publication number Publication date
WO1999020315A1 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
AU9281298A (en) Benzodioxole derivatives
PL326882A1 (en) Method of obtaining vanilin
AU4080499A (en) Heterogeneous display elements and methods for their fabrication
AU7419900A (en) Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
AU5324099A (en) Methods for predicting drug response
AU5827298A (en) Method of making retroreflective elements
AU7060798A (en) Design of computer networks
AU5134599A (en) Expression of functional eukaryotic proteins
AU6015098A (en) Method of screening agents as candidates for drugs or sources of drugs
AU3331399A (en) Stabilisation of organic materials
AU6940998A (en) Phospholipid drug derivatives
AU1991799A (en) Molecules associated with the human suppressor of fused gene
AU1118099A (en) Methods of screening potential atypical antipsychotic drugs
AU1788800A (en) Derivative of paroxetine
AU1197599A (en) Detection of neurodegenerative diseases
AU4001297A (en) Capsule
ZA982948B (en) Chromatographic separation of enantiomers of lactones
AU2559599A (en) Detection of genetic information
AU8817398A (en) Method of drug selection
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU7103598A (en) Measurement of fluorescence
AUPO565997A0 (en) Propanolamine derivatives
PL335675A1 (en) Anticonvulsive derivatives of isoquinolinbenzamide
AU1678499A (en) Detection of analytes
AU5299200A (en) A nematode drug screen for modulators of mammalian disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase